{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:34:40Z","timestamp":1793921680654,"version":"4.8.0"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"20","content-domain":{"domain":["www.ahajournals.org"],"crossmark-restriction":true},"short-container-title":["Circulation"],"published-print":{"date-parts":[[2020,5,19]]},"abstract":"<jats:p>Coronavirus disease 2019 (COVID-19) is a global pandemic affecting 185 countries and &gt;3\u2009000\u2009000 patients worldwide as of April 28, 2020. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2, which invades cells through the angiotensin-converting enzyme 2 receptor. Among patients with COVID-19, there is a high prevalence of cardiovascular disease, and &gt;7% of patients experience myocardial injury from the infection (22% of critically ill patients). Although angiotensin-converting enzyme 2 serves as the portal for infection, the role of angiotensin-converting enzyme inhibitors or angiotensin receptor blockers requires further investigation. COVID-19 poses a challenge for heart transplantation, affecting donor selection, immunosuppression, and posttransplant management. There are a number of promising therapies under active investigation to treat and prevent COVID-19.<\/jats:p>","DOI":"10.1161\/circulationaha.120.046941","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T23:29:23Z","timestamp":1584833363000},"page":"1648-1655","update-policy":"https:\/\/doi.org\/10.1161\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1412,"title":["COVID-19 and Cardiovascular Disease"],"prefix":"10.1161","volume":"141","author":[{"given":"Kevin J.","family":"Clerkin","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin A.","family":"Fried","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant","family":"Raikhelkar","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sayer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan M.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirali","family":"Masoumi","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha S.","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Burkhoff","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepa","family":"Kumaraiah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeRoy","family":"Rabbani","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Schwartz","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nir","family":"Uriel","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Cardiology, Columbia University Vagelos College of Physicians and Surgeons, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(20)30120-1"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.8.686"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.06.015"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0820-9"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cub.2020.03.022"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.26.919985"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/256294"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05985-9"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2001737"},{"key":"e_1_3_3_12_2","unstructured":"World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). https:\/\/www.who.int\/publications-detail\/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19). Published 2020. Accessed February 28 2020."},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2004973"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2002032"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0504"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0822-7"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp2000929"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.21.JOC30885"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.06.015"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0360-5"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.017"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa190"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202003.0180.v1"},{"key":"e_1_3_3_27_2","unstructured":"Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/clinical-guidance-management-patients.html. Revised March 7th 2020. Accessed March 21 2020."},{"key":"e_1_3_3_28_2","doi-asserted-by":"crossref","unstructured":"World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. https:\/\/www.who.int\/publications-detail\/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Published March 13 2020. Accessed March 21 2020.","DOI":"10.15557\/PiMR.2020.0003"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2009.02153.x"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.289.21.JOC30885"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000124667.34652.1a"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.510461"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2005.07.026"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.12573"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euw246"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1042\/CS20120162"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi114"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature03712"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm1267"},{"key":"e_1_3_3_40_2","unstructured":"Randomized Controlled Trial of Losartan for Patients With COVID-19 Not Requiring Hospitalization. ClinicalTrials.gov identifier: NCT04311177. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04311177. March 17 2020. Accessed March 21 2020."},{"key":"e_1_3_3_41_2","unstructured":"Randomized Controlled Trial of Losartan for Patients With COVID-19 Requiring Hospitalization. ClinicalTrials.gov identifier: NCT04312009. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04312009. March 17 2020. Accessed March 21 2020."},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.13085"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00197.x"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.03.006"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2020.03.008"},{"key":"e_1_3_3_46_2","unstructured":"Guidance for cardiothoracic transplant and mechanical circulatory support centers regarding SARS CoV-2 infection and COVID-19. https:\/\/community.ishlt.org\/HigherLogic\/System\/DownloadDocumentFile.ashx?DocumentFileKey=afb06f06-5d63-13d4-c107-d152a9f6cd46. Published March 17 2020. Accessed March 21 2020."},{"key":"e_1_3_3_47_2","unstructured":"American Society of Transplantation. 2019-nCoV (coronavirus): FAQs for organ transplantation. https:\/\/www.myast.org\/sites\/default\/files\/COVID19%20FAQ%20Tx%20Centers%20030220-1.pdf. Updated February 29 2020. Accessed March 21 2020."},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001316"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-017-1823-x"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00094-12"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.AC120.013056"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1922083117"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"e_1_3_3_54_2","unstructured":"Severe 2019-nCoV Remdesivir RCT. ClinicalTrials.gov identifier: NCT04257656. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04257656. Updated February 24 2020. Accessed March 21 2020."},{"key":"e_1_3_3_55_2","unstructured":"Mild\/Moderate 2019-nCoV Remdesivir RCT. ClinicalTrials.gov identifier: NCT04252664. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04252664. Updated February 24 2020. Accessed March 21 2020."},{"key":"e_1_3_3_56_2","unstructured":"Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734\u2122) in Participants With Severe Coronavirus Disease (COVID-19). ClinicalTrials.gov identifier: NCT04292899. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04292899. Updated March 19 2020. Accessed March 21 2020."},{"key":"e_1_3_3_57_2","unstructured":"Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734\u2122) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment. ClinicalTrials.gov identifier: NCT04292730. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04292730. Updated March 19 2020. Accessed March 21 2020."},{"key":"e_1_3_3_58_2","unstructured":"Comparison of Lopinavir\/Ritonavir or Hydroxychloroquine in Patients With Mild Coronavirus Disease (COVID-19). ClinicalTrials.gov identifier: NCT04307693. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04307693. Updated March 13 2020. Accessed March 21 2020."},{"key":"e_1_3_3_59_2","unstructured":"Efficacy and Safety of Hydroxychloroquine for Treatment of Pneumonia Caused by 2019-nCoV (HC-nCoV). ClinicalTrials.gov identifier: NCT04261517. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04261517. Updated March 4 2020. Accessed March 21 2020."},{"key":"e_1_3_3_60_2","unstructured":"Post-exposure Prophylaxis for SARS-Coronavirus-2. ClinicalTrials.gov identifier: NCT04308668. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04308668. Updated March 19 2020. Accessed March 21 2020."},{"key":"e_1_3_3_61_2","unstructured":"Chloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting (COPCOV). ClinicalTrials.gov identifier: NCT04303507. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04303507. Updated March 11 2020. Accessed March 21 2020."},{"key":"e_1_3_3_62_2","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.01047"},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.2003.012658"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2001282"},{"key":"e_1_3_3_65_2","doi-asserted-by":"publisher","DOI":"10.2183\/pjab.93.027"},{"key":"e_1_3_3_66_2","unstructured":"Tocilizumab in COVID-19 Pneumonia (TOCIVID-19). ClinicalTrials.gov identifier: NCT04317092. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04317092. Updated March 20 2020. Accessed March 21 2020."},{"key":"e_1_3_3_67_2","unstructured":"Tocilizumab vs CRRT in Management of Cytokine Release Syndrome (CRS) in COVID-19 (TACOS). ClinicalTrials.gov identifier: NCT04306705. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04306705. Updated March 17 2020. Accessed March 21 2020."},{"key":"e_1_3_3_68_2","unstructured":"Tocilizumab for SARS-CoV2 Severe Pneumonitis. ClinicalTrials.gov identifier: NCT04315480. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04315480. Updated March 19 2020. Accessed March 21 2020."},{"key":"e_1_3_3_69_2","unstructured":"Evaluation of the Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19. ClinicalTrials.gov identifier: NCT04315298. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04315298. Updated March 19 2020. Accessed March 21 2020."}],"container-title":["Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ahajournals.org\/doi\/full\/10.1161\/CIRCULATIONAHA.120.046941","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:35:44Z","timestamp":1715589344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ahajournals.org\/doi\/10.1161\/CIRCULATIONAHA.120.046941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,19]]},"references-count":68,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2020,5,19]]}},"alternative-id":["10.1161\/CIRCULATIONAHA.120.046941"],"URL":"https:\/\/doi.org\/10.1161\/circulationaha.120.046941","relation":{},"ISSN":["0009-7322","1524-4539"],"issn-type":[{"value":"0009-7322","type":"print"},{"value":"1524-4539","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,19]]},"assertion":[{"value":"2020-03-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}